Generics Bulletin is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People Roundup – 26 March 2019

Executive Summary

The latest people movements in the generics and biosimilars industries include Akorn gaining a head of quality, Polpharma naming a chief commercial officer, Pfenex appointing a new chief scientific officer, Coherus announcing a new legal head, Mallinckrodt recruiting a former Impax chief financial officer, and board changes at Krka, Advanz and Hikma.


Related Content

Mallinckrodt Sets Out Four Priorities For 2019 And Foresees Specialty Generics Growth
Akorn Hit With FDA Warning For Decatur Site In US
Akorn's Chief Steps Down After Losing Kabi Deal
Chagnaud assists Concordia





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts